HCA HCA Healthcare, Inc.

NYSE hcahealthcare.com


$ 445.00 $ -1.03 (-0.23 %)    

Thursday, 23-Oct-2025 19:19:57 EDT
QQQ $ 611.71 $ 5.09 (0.84 %)
DIA $ 467.15 $ 1.51 (0.32 %)
SPY $ 672.28 $ 3.96 (0.59 %)
TLT $ 91.36 $ -0.63 (-0.68 %)
GLD $ 378.20 $ 1.51 (0.4 %)
$ 440.16
$ 440.49
$ 437.60 x 1
$ 445.00 x 9
$ 439.02 - $ 447.09
$ 288.25 - $ 447.09
1,924,066
na
102.99B
$ 0.90
$ 17.25
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-04-2025 06-30-2025 10-Q
2 05-01-2025 03-31-2025 10-Q
3 02-13-2025 12-31-2024 10-K
4 10-31-2024 09-30-2024 10-Q
5 07-29-2024 06-30-2024 10-Q
6 05-02-2024 03-31-2024 10-Q
7 02-16-2024 12-31-2023 10-K
8 10-26-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 04-27-2023 03-31-2023 10-Q
11 02-17-2023 12-31-2022 10-K
12 11-01-2022 09-30-2022 10-Q
13 08-01-2022 06-30-2022 10-Q
14 05-03-2022 03-31-2022 10-Q
15 02-18-2022 12-31-2021 10-K
16 11-01-2021 09-30-2021 10-Q
17 08-02-2021 06-30-2021 10-Q
18 04-30-2021 03-31-2021 10-Q
19 02-19-2021 12-31-2020 10-K
20 10-29-2020 09-30-2020 10-Q
21 07-30-2020 06-30-2020 10-Q
22 05-06-2020 03-31-2020 10-Q
23 02-20-2020 12-31-2019 10-K
24 11-01-2019 09-30-2019 10-Q
25 08-02-2019 06-30-2019 10-Q
26 05-03-2019 03-31-2019 10-Q
27 02-21-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-03-2018 06-30-2018 10-Q
30 05-08-2018 03-31-2018 10-Q
31 02-23-2018 12-31-2017 10-K
32 11-07-2017 09-30-2017 10-Q
33 08-04-2017 06-30-2017 10-Q
34 05-09-2017 03-31-2017 10-Q
35 02-22-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-06-2016 03-31-2016 10-Q
39 02-26-2016 12-31-2015 10-K
40 10-29-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 what-to-expect-when-hca-healthcare-reports-q3-earnings-on-friday

HCA Healthcare Q3 earnings eyed at $5.72 per share, backed by patient growth, DPP contributions, and favorable payor trends.

 retail-investors-top-stocks-with-earnings-this-week-tesla-netflix-intel-and-more

Retail investors prepare for the first busy week in the Q3 earnings season, with Tesla, Netflix and Intel on deck.

 mizuho-maintains-outperform-on-hca-healthcare-raises-price-target-to-475

Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $425 to $475.

 ubs-maintains-buy-on-hca-healthcare-raises-price-target-to-495

UBS analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $438 to $495.

 goldman-sachs-assumes-hca-healthcare-at-buy-announces-price-target-of-470

Goldman Sachs analyst Scott Fidel assumes HCA Healthcare (NYSE:HCA) with a Buy rating and announces Price Target of $470.

 keybanc-maintains-overweight-on-hca-healthcare-raises-price-target-to-465

Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $370 ...

 wells-fargo-maintains-equal-weight-on-hca-healthcare-raises-price-target-to-412

Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from ...

 cantor-fitzgerald-reiterates-overweight-on-hca-healthcare-maintains-444-price-target

Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $444 price target.

 if-you-invested-1000-in-hca-healthcare-stock-5-years-ago-you-would-have-this-much-today

HCA Healthcare (NYSE: HCA) has outperformed the market over the past 5 years by 12.38% on an annualized basis producing an aver...

 hca-healthcare-selects-hyderabad-for-first-gcc-in-india-commits-75m-and-3000-professional-roles-by-202

-Reuters

 premier-set-for-private-ownership-eyes-growth-push

Premier Inc. to be acquired by Patient Square Capital at $28.25 per share, offering shareholders a 23.8% premium.

 barclays-maintains-overweight-on-hca-healthcare-raises-price-target-to-445

Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $390 to $...

 b-of-a-securities-maintains-neutral-on-hca-healthcare-raises-price-target-to-410

B of A Securities analyst Joanna Gajuk maintains HCA Healthcare (NYSE:HCA) with a Neutral and raises the price target from $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION